Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ThinkingNodeLife.ai has developed an advanced AI-powered platform that creates mechanistic human digital cell clones using patient gene expression data. This enables accurate prediction of cellular responses to drugs, supporting target discovery, mechanism validation, biomarker identification, and drug combination strategies. The technology is being applied in oncology and autoimmune diseases through partnerships such as with Debiopharm to expand indications for existing cancer drugs and optimize R&D processes. No direct clinical results are reported as the company does not sponsor its own trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ThinkingNodeLife.ai.